During the past decade, Krankenhaus Reinbek, St. Adolf Stift conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus Reinbek, St. Adolf Stift" #1 sponsor was "ResMed" with 3 trials, followed by "Biotronik SE & Co. KG" with 2 trials sponsored, "Advanz Pharma" with 1 trials sponsored, "Aesculap AG" with 1 trials sponsored and "Cogentus Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Reinbek, St. Adolf Stift" #1 collaborator was "B. Braun Medical France" with 1 trials as a collaborator, "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator, "Raylytic GmbH" with 1 trials as a collaborator and "Sorin CRM" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus Reinbek, St. Adolf Stift" are "Atrial Fibrillation" (2 trials), "Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials), "Arthritis, Rheumatoid" (1 trials) and "Cardiac Arrhythmias" (1 trials). Many other conditions were trialed in "Krankenhaus Reinbek, St. Adolf Stift" in a lesser frequency.

Most popular intervention types in "Krankenhaus Reinbek, St. Adolf Stift" are "Device" (6 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Amiodarone Injection:" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "Cardiac resynchronisation therapy" (1 trials), "Europe: AutoSet CS (USA: VPAP Adapt SV)" (1 trials) and "Implantable cardioverter-defibrillator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus Reinbek, St. Adolf Stift" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Krankenhaus Reinbek, St. Adolf Stift". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Krankenhaus Reinbek, St. Adolf Stift, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus Reinbek, St. Adolf Stift, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".